Question explored with the scientific record
What studies are being done on DMSO and do they show any health benefits from its use?
The short version: DMSO has real, narrow evidence in a few conditions and is mostly used as a carrier that drags other drugs through skin. It is not a proven general health tonic.
What the search surfaced is thin and mostly not about DMSO as a standalone treatment. The clearest human signal is in bladder pain (interstitial cystitis): one controlled study found intravesical DMSO gave both subjective and objective improvement over placebo, but most studies of that use were uncontrolled [4]. A randomized crossover trial found a better response to DMSO than to BCG, a competing bladder treatment [4]. That is one narrow use, delivered into the bladder by a doctor, not swallowed or rubbed on.
The rest is animal and lab work. In rabbits with acid eye burns, 40% DMSO healed the cornea faster than indomethacin or control [1]. In mice, low-dose topical DMSO cut inflammatory markers [3], and 5 mM DMSO sped wound healing in diabetic mice while 20 mM delayed it [3]. None of that is proof it helps a person.
| Finding | Where tested | Human proof? |
|---|---|---|
| Bladder pain relief | Interstitial cystitis patients | One controlled study [4] |
| Faster eye-burn healing | Rabbits | No [1] |
| Lower inflammation | Mice, cells | No [3] |
| Better drug absorption through skin | Human volunteers | Yes, as a carrier [3] |
On safety, a review of 109 studies found reactions mostly mild and short-lived, chiefly stomach and skin, and tied to dose [2]. Nausea hit about 17 in 100 with intravenous DMSO versus about 5 in 100 applied to skin [2]. That review inherits publication bias, so treat it as a floor, not a ceiling.
My call: DMSO is worth considering only for doctor-delivered bladder instillation, and even there the controlled evidence is a single study. As a rub-on or swallowed health remedy, the human evidence is not there. Confidence: low to moderate.
Sources used 4
-
Dimethyl sulfoxide but not indomethacin is efficient for healing in hydrofluoric acid eye burns
This study investigates the efficacy of dimethyl sulfoxide (DMSO) compared to indomethacin in promoting healing of hydrofluoric acid-induced eye burns in rabbits, finding that DMSO significantly enhances reepithelization and reduces inflammation.
DOI: 10.1016/j.burns.2016.09.026 -
Adverse reactions of dimethyl sulfoxide in humans: a systematic review
In a systematic review of 109 studies, DMSO was associated with mostly transient, mild adverse reactions, most commonly gastrointestinal and skin reactions, with reaction occurrence appearing dose-related.
DOI: 10.12688/f1000research.16642.2 -
Dimethyl sulfoxide in topical pharmaceutical drug development: A fresh perspective
A narrative review proposes that high-purity (>99.99%) DMSO is an effective, underused topical penetration enhancer with anti-inflammatory and analgesic activity, and that higher purity may reduce the halitosis historically associated with topical DMSO.
DOI: 10.66617/001c.120609 -
Therapeutic options in the management of interstitial cystitis
This narrative review summarizes therapeutic options for interstitial cystitis, noting that evidence for most treatments is limited by high placebo response and few controlled trials.
DOI: 10.1016/s1471-7697(03)00092-3